Abcam Fundamentals

ABCM
 Stock
  

USD 15.35  0.11  0.72%   

Abcam Plc ADR fundamentals help investors to digest information that contributes to Abcam Plc's financial success or failures. It also enables traders to predict the movement of Abcam Stock. The fundamental analysis module provides a way to measure Abcam Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abcam Plc stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Abcam Plc Operating Income is relatively stable at the moment as compared to the past year. The company's current value of Operating Income is estimated at 6.56 Million. Research and Development Expense is expected to hike to about 32.5 M this year, although the value of Gross Profit will most likely fall to nearly 249.4 M.

Abcam Market Capitalization Analysis

Abcam Plc's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
More About Market Capitalization | All Equity Analysis

Current Abcam Plc Market Capitalization

    
  3.62 B  
Most of Abcam Plc's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abcam Plc ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Abcam Market Capitalization Historical Pattern

Today, most investors in Abcam Plc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Abcam Plc's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's market capitalization growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Abcam Plc market capitalization as a starting point in their analysis.
   Abcam Plc Market Capitalization   
Share
       Timeline  
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Compare to competition

Based on the recorded statements, the market capitalization of Abcam Plc ADR is about 3.62 B. This is 72.03% lower than that of the Healthcare sector and 23.64% lower than that of the Biotechnology industry. The market capitalization for all United States stocks is 80.98% higher than that of the company.

Abcam Plc ADR Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Abcam Plc's current stock value. Our valuation model uses many indicators to compare Abcam Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abcam Plc competition to find correlations between indicators driving Abcam Plc's intrinsic value. More Info.
Abcam Plc ADR is number one stock in z score category among related companies. It is number one stock in net income category among related companies making up about  229,167  of Net Income per Z Score. Abcam Plc Net Income is relatively stable at the moment as compared to the past year. The company's current value of Net Income is estimated at 4.06 Million. Comparative valuation analysis is a catch-all model that can be used if you cannot value Abcam Plc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Abcam Plc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abcam Plc's earnings, one of the primary drivers of an investment's value.

Abcam Plc Institutional Holders

Institutional Holdings refers to the ownership stake in Abcam Plc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Abcam Plc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Abcam Plc's value.
Security TypeSharesValue
Wellington Management Group LlpCommon Shares8.4 M122.1 M
Brown Advisory IncCommon Shares3.2 M45.9 M
Champlain Investment Partners LlcCommon Shares3.2 M45.6 M
Rock Springs Capital Management LpCommon Shares1.6 M23.4 M
Price T Rowe Associates IncCommon Shares1.6 M22.5 M
Blackrock IncCommon Shares1.5 M21.2 M
Janus Henderson Group PlcCommon SharesM14.8 M

Abcam Fundamentals

About Abcam Plc Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abcam Plc ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abcam Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abcam Plc ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Cost of Revenue104.4 M102.7 M
Revenues362.7 M352.1 M
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. Abcam Plc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1650 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abcam Plc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abcam Plc's short interest history, or implied volatility extrapolated from Abcam Plc options trading.

Pair Trading with Abcam Plc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abcam Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcam Plc will appreciate offsetting losses from the drop in the long position's value.

Moving against Abcam Plc

0.51ACURAcura Pharma Cmn Earnings Call  This WeekPairCorr
The ability to find closely correlated positions to Abcam Plc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abcam Plc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abcam Plc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abcam Plc ADR to buy it.
The correlation of Abcam Plc is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abcam Plc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abcam Plc ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abcam Plc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Abcam Plc Piotroski F Score and Abcam Plc Altman Z Score analysis. Note that the Abcam Plc ADR information on this page should be used as a complementary analysis to other Abcam Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Abcam Stock analysis

When running Abcam Plc ADR price analysis, check to measure Abcam Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcam Plc is operating at the current time. Most of Abcam Plc's value examination focuses on studying past and present price action to predict the probability of Abcam Plc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abcam Plc's price. Additionally, you may evaluate how the addition of Abcam Plc to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Is Abcam Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcam Plc. If investors know Abcam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcam Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.58
Market Capitalization
3.5 B
Quarterly Revenue Growth YOY
0.23
Return On Assets
0.0326
Return On Equity
0.0069
The market value of Abcam Plc ADR is measured differently than its book value, which is the value of Abcam that is recorded on the company's balance sheet. Investors also form their own opinion of Abcam Plc's value that differs from its market value or its book value, called intrinsic value, which is Abcam Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcam Plc's market value can be influenced by many factors that don't directly affect Abcam Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcam Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine Abcam Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcam Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.